Search
- Page Path
-
HOME
> Search
Case Reports
- Hepatocellular carcinoma with Budd-Chiari syndrome due to membranous obstruction of the inferior vena cava with long-term follow-up: a case report
-
Choong Hee Kim, Gwang Hyeon Choi, Hee Young Na, Chang Jin Yoon, Jai Young Cho, Sangmi Jang, Ji Hye Kim, Eun Sun Jang, Jin-Wook Kim, Sook-Hyang Jeong
-
J Liver Cancer. 2022;22(2):194-201. Published online September 15, 2022
-
DOI: https://doi.org/10.17998/jlc.2022.08.24
-
-
Abstract
PDF
- Membranous obstruction of the inferior vena cava (MOVC) is a rare subset of Budd-Chiari syndrome (BCS) with a subacute onset that is often complicated by cirrhosis and hepatocellular carcinoma (HCC). Here we report a case of recurrent HCC in a patient with cirrhosis and BCS that was treated with several episodes of transarterial chemoembolization followed by surgical tumorectomy, whereas the MOVC was successfully treated with balloon angioplasty followed by endovascular stenting. The patient was followed up for 9.9 years without anticoagulation and experienced no stent thrombosis. After the tumorectomy, the patient was HCC-free for 4.4 years of follow-up.
- A Case of Rapid Progressive Extrahepatic Metastasis of Hepatocellular Carcinoma after Surgical Resection for Huge Single Mass
-
Eun Sun Jang, Haeryoung Kim, Young Rok Choi, Jai Young Cho, Yoo-Seok Yoon, Ho-Seong Han, Ji Hyun Kim, Jin-Wook Kim, Sook-Hyang Jeong
-
J Liver Cancer. 2016;16(1):42-46. Published online March 31, 2016
-
DOI: https://doi.org/10.17998/jlc.16.1.42
-
-
Abstract
PDF
- Hepatocellular carcinoma (HCC) shows a poor prognosis with high recurrence rate even after
surgical resection. To improve prognosis of HCC patient, regular surveillance for high-risk
group is recommended, but cost-benefit of the surveillance under 40 years old Asian male
with hepatitis B infection is unclear. We share a 39-year-old male case which showed early
recurrence and rapid extrahepatic metastasis after surgical resection for single huge HCC.
Based on the pathologic finding, this case was diagnosed with ‘stemness’-related markerexpressing
HCC. Further molecular classification for HCC could be beneficial to estimate
individual risk for HCC recurrence and to predict prognosis.